GB2129691A - Devices for administering medicaments to patients - Google Patents
Devices for administering medicaments to patients Download PDFInfo
- Publication number
- GB2129691A GB2129691A GB08326878A GB8326878A GB2129691A GB 2129691 A GB2129691 A GB 2129691A GB 08326878 A GB08326878 A GB 08326878A GB 8326878 A GB8326878 A GB 8326878A GB 2129691 A GB2129691 A GB 2129691A
- Authority
- GB
- United Kingdom
- Prior art keywords
- chamber
- support
- medicament
- carrier
- mouthpiece
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0003—Details of inhalators; Constructional features thereof with means for dispensing more than one drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0035—Piercing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6063—Optical identification systems
- A61M2205/6081—Colour codes
Description
1
SPECIFICATION
Devices for administering medicaments to patients This invention relates to devices by which a medicament can be administered to or by patients inhaling through the devices. The medicaments may be in solid finely divided form orfluid form. Such devices are now quite well known for administering medicaments contained in capsules to patients suffer ing from bronchial conditions such as, for example, bronchial asthma. It is well known for medicament in powderor other dinely divided form to be supplied in capsules which are loaded by a patient into such a device which is sometimes called an "insufflator". The medicament isthen released from the capsule and inhaled bythe patient, usuallythrough the mouth, but sometimes through the nose.
The specifications of PCTApplication Publication
No. W082/01470 and U.K. Patent Specification No. 85
1387954 both described devices for dispensing medicament in finely divided form from capsules. In each of these previously described devices, the capsules are mounted on a rotatable support member on which each capsule in turn can be broughtto a 90 position in which it is opened to enable medicamentto exitfrom the capsule to permit itto be inhaled by a patient inhaling through a mouthpiece of the device.
In the device described in U.K. Specification No.
1387954, the capsules may be mounted in a so-called 95 blister pack.
There are disadvantages in the use of capsules, which are made of gelatin, to contain medicaments.
Gelatin is relatively unstable and is lacking in physical strength so thatthe capsules need to be protected by 100 packaging, for example in glass bottles. Environmen tal degradation of both the capsules and their contents may occure in a relatively shorttime.
An object of the present invention is to provide a more convenient way of administering medicament 105 to such patients than has been possible hitherto and which avoidsthe need to pack medicaments in capsules. The device of the present invention makes use of thetechnique of packing medicament by loading them in blister packs, that is to say packs 110 comprising a sheet, which may be laminated, of foil or plastics material which acts as a carrier and which is provided with a number of breakable or openable containers called "blisters" incorporating a sheet secured on a first sheetto form a cover or lid. Such blister packs are in common use with tablets of one kind or another, butwe have discovered that they can also be used with medicaments in finely divided solid form or in liquid form.
According to the present invention a device for administering medicaments to patients comprises a housing with a cylindrical chambertherein; an air inlet into the chamber; a support insidethe chamber arranged to support a carrier provided with a contain- erfor medicament or a plurality of containers arranged in a circle; a plunger operableto engage a container registered therewith to open the container in such a way that air being inhaled by a patient will cause the medicamentto be released therefrom; means for rotating a carrier on the support to register GB 2 129 691 A 1 the container, or each ofthem inturn, with the plunger; and communicating with the interiorof the chamber, an outletthrough which a patientcan inhale whereby medicamentwill be releasedfrom a contain- erand entrained in theairflow produced bythe patient so asto passthroughthe outlet. The outletis conveniently but not essentially a mouthpiece by which a patient can inhale.
The device of the invention is suitablefor admi- nistering a variety of medicaments such as, for example, salbutamol, beclomethasone dipropionate and disodiurn cromoglycate.
Some embodiments of the invention are illustrated in the accompanying schematic drawings in which; Figure 1 is an exploded perspective view of a device according to one embodiment of the invention; Figure 2 is a detailed view of a plunger device of the same device; Figure 3 is an elevation of another embodiment of the invention; Figure 4 is an exploded view of the embodiment illustrated in Figure 3, and Figure 5 is a perspective view of yet another embodiment of the invention.
In the embodiment of the invention illustrated in Figures 1 and 2 of the drawings, a medical administration device comprises a shallow cylindrical housing 1 of a plastics material which has a cylindrical chamber 2 therein. The chamber is closed at one end 3, herein considered the bottom of the chamber, and a removable cover 4 is a close fit overthe chamber atthe other end.
A mouthpiece outlet 5 projects outwardlyfrorn the cylindrical wall of the housing 1 and communicates with the interior of the chamber 2. A perforated guard, not shown, is provided in the mouthpieceto prevent any solid particles of an undesirably large size being inhaled by a patient inhaling through the mouthpiece.
A rim orshoulder 6 runs round the inside wall of the chamber 2 to provide an annular support on which a blister pack7 may be located.
The blister pack 7 can conveniently be a foil laminate with a plurality of frangible containers or "blisters" 8 arranged in a circle. The blisters 8 are filled with medicament in particulate form, having a particle size in the range of 0.5 - 10 microns. The medicament may be with a pharmaceutically acceptable carrier such as lactose or starch in particulate form. Alternatively, the medicament may be in liquid form. The blister pack is of circular discform, and is removablyfitted inside the chamber so that it is replaceable when the individual doses of medicament contained in the blisters have been discharged.
The chamber 2 contains a central open cylindrical support column 9 upstanding from the bottom wall 3 of the chamber. A clamp disc member 10 is removably fitted inside the chamber 2 and has on its underside a plurality of locating pegs, not shown, which engage inside the support column. The clamp member 10 is rotatable inside the chamber. In use, the clamp member is placed on top of a blister pack 7 which has already been loaded into the chamber and is located on the support shoulder 6. The blister pack7 is preferably a circular disc of foil laminate material with blisters or containers 8. The clamp member 10 has a 2 plurality of apertures 11 which are arranged in a circle and so spaced from each other that each of them will receive one of the blisters 8 of the blister pack 7. A knob 12 is upstanding from the clamp member 10 and when the lid 4 is fitted on the housing 1 the knob 12wil 1 70 project through an aperture 13 in the top of the lid 4.
This knob can be turned by the patient to rotate the clamp member 10 and since the blisters 8 of the blister pack 7 are located in the apertures 11 in the clamp plate 10 rotation of the clamp mem ber wil I also rotate 75 the blister pack. A plurality of protuberances or pips 14 are provided on the top of the clamp member 10 and engage in a recess 15, Figu re 2, on the underside of the cover 4 to make sure that the clamp plate is correctly aligned in position. As wil I be seen, the knob 12 is 80 fluted to provide openings between the knob and the hole 13 through which air can enterthe chamber 2 from the outside.
The cover 4 also has an aperture 16 in which a plunger 17 contained in a plunger housing 18 can be 85 received. The plunger has an annular shoulder 19 and a spring 20 can bear between the shoulder 19 and the bottom of the plunger housing 18 to urge the plunger into an upper or inoperative position. The plunger may be provided with a knife edge 21 or other means 90 to enable the blisterto be opened. When the plunger 17 is depressed against the action of the spring 20, the lower edge portion 21 of the plungerwill pass through an aperture 22 in the plunger housing to passthrough a blister 8 located in registerwith the plunger. Such 95 engagementwill open the blister, and permitthe release of medicament therefrom. This action will so open the blisterthat when a patient inhales airwill pass through the blister, the medicament being entrained in the airflow and exiting through the 100 mouthpiece 5 via a transfer cavity 23 inside the chamber in communication with the mouthpiece 5. By rotation of the knob 12the clamp member 10 and the blister pack 7 can be rotated to bring each blister in turn into location beneath the plunger. The various 105 protuberances or pips 14 will in turn engage in the recess 15 to make sure that the blister pack is correctly registered with the plunger.
It is not essential that the plunger have a knife 21 to - open the blister. If desired a needle can be used to 110 perforate the blister orthe plunger may have a pointed end or even a blunt end or another convenient opening means my be used.
The mouthpiece cover can have a locking member 24which can be engaged with the plunger when the 115 device is not in use to prevent accidental actuation of the plunger.
In use,the patient needing a dose of medicament may hold the device with the mouthpiece in his mouth.The patientthen depressesthe plungerto openthe blisterand give accesstothe medicament therefrom and inhales through the mouthpiece so that the medicamentwill be entrained inthe airflowand will enterthe I u ngs of the patient. If desired, the mouthpiece can be provided with air inlet apertures 25 to improve the air flow as the patient inhales.
Ina modification no illustrated the underside of the blister pack can be supported on another clamp plate instead of the support rim or shoulder 6.
The blister pack is conveniently arranged to provide 130 GB 2 129 691 A 2 a sufficient number of individual dosesfora patientfor use during a convenient period such as one day or more. The housing can be modified by providing an additional chamber, not visible, atthe bottom, this additional chamber being closed by a removable cover 26. This additional chamber can be used to store replacement blister packs.
The mouthpiece may, if desired, be arranged so that a patient may use itto inhale through the nose.
A modified device which does not usethe clamp member 10 is illustrated in Figures 3 and 4. The device of this modification comprises a housing 30 having a chamber31 therein. A mouthpiece 32 projects outwardlyfrom the cylindrical wall of the housing 30 in a generally radial direction and communicates with the interior of the chamber 31. A perforated guard 33 is provided atthe entrance to the mouthpiece 32. A rim orshoulder34 runs round the inside wall of the chamber 31 to provide an annularsupport for a support member35 in the form of a circular plate or disc. This support member is arranged to receive a blister pack 36. The blister pack 36 has a plurality of frangible containers 37 arranged in a circular row. These containers are in theform of -blisters" of a generally conical form as clearly shown in Figure 4 and contain a medicament as described with reference to Figure 1. The support member35 has a plurality of holes 38 equal in numberto the number of blisters 37 of the blister pack 36. The conical portion of one blister37 is located in each of the holes 38 when the device is loaded and in use. An external rotatable member39 with a knurled edge 40 is located in face contactwith the bottom of the housing 30. Aspindle or the like 41 with radial projections 42 extends centrally from the support member35through a hole 43 in the bottom of the housing 30 and into an opening 44 of complementary shape in a spigot 45 of the member 39. The spigot45 passes through the hole 43 and the spindle 41 and 42 engages in the opening 44 so that rotation of the member 39 will cause similar rotation to the support member 35. A removable cover 46 fits on top of the housing 30. An opening 47 is provided in the cover 46 and engages a projection 48 in the housing 30 so as correctlyto locate the cover. The cover 46 carries a bracket 49 on which a lever ortrigger 50 is pivotally mounted. A plunger 51 is located on the lever ortrigger 50 and extends through a hole 52 in the cover. A spring 53 is provided to bear between the trigger or lever 50 and the top of the cover 46 to urge the lever ortrigger upwards.
The hole 52 is so positioned that each hole 38 in the su pport member 35 wil 1 registerwith this hole as the support member35 is rotated.
When one of the holes 38 is in registerwith the hole 52thetrigger 50 can be depressed so that its plunger 51, which may be intheform of a needle,will pierce through the blister37 located in that hole (i.e. pierce thetop andthe bottom of the blister) therebyto permit powderto exitfrom the blister. Some powderwill fall into atray-like compartment 54 inside the chamber 31. When the patientinhales, air passesthrough the pierced blistersothat powderwill be entrained in the airflowand will,with powderfrom the compartment 54, be withdrawn through the guard 33 andthe ice is not in use, the mouthpiece 32. When the devi 3 GB 2 129 691 A 3 mouthpiece32can beenclosed in a mouthpiece cover orsheath 55which has a channel-like extension 56 which will engagewith the bracket49to preveritthe plunger51 being depressed to enterth rough the hole 37.
When the device is in use and the patient inhales through the mouthpiece 32 it is, of course, essential for airto be able to enterthe interior of the chamber31.
Any suitable air inlets can be provided. Conveniently, however, air can enterthrough the hole 52 the plunger or needle 51 being smaller in diameterthan the diameter of the hole 52 so that it serves as an air inlet.
Figure 5 illustrates a modified device which can conveniently be used to administertwo different medicaments to a patient at separate times. Treat ment of certain patients does require that they inhale two different kinds of medicament. In the device illustrated in Figure 5, a common housing 57 contains two chambers equivaleritto the chamber 2 of the embodiment illustrated in Figure 1 and 2 orto the 85 chamber31 of the embodiment illustrated in Figures 3 and 4. These two chambers are enclosed by remov able covers 58 and blister packs contained in the chambers can be rotated in the manner previously described by rotation of knurled wheels, knobs or other members 59. Outlet mouthpieces 60 project outwardlyfrom the common housing 57, each one of these outlets 60 leading into one of the chambers enclosed bythe common housing. Trigger mechan isms 61 are provided to enable the blisters of the blister packs contained in the chambers to be pierced so that the contents thereof can be inhaled by the patient.
Claims (17)
1. A device for administering medicaments to patients comprises a housing with a cylindrical chambertherein; an air inlet into the chamber; a support insidethe chamber arranged to support a carrier provided with a containerfor medicament or a plurality of containers arranged in a circle; a plunger operable to engage a container registered therewith to open the container in such a way that air being inhaled by a patient will causethe medicamentto be released therefrom; means for rotating a carrier on the supportto registerthe container, or each of them in turn,with the plunger; and, communicating with the interior of the chamber, an outletthrough which a patient can inhale whereby medicamentwill be released from a container and entrained in the airflow produced by the patient so as to pass through the 115 outlet.
2. A device as claimed in claim 1 wherein the support is a rotatable plate with a plurality of holes therethrough,the holes being arranged in a circle and each being adapted to receive a containerfor medica- 120 ment, a rotatable member is located outside the chamber and is connected with the support so that rotation of the said member will cause rotation of the support; a mouthpiece outlet leads out of the chamber in a substantially radial direction; and a perforated guard is positioned so that air and medicament inhaled through the mouthpiece will first pass through theguard.
3. A device as claimed in claim 1 wherein the support is a rim inside the chamber and a clamp member is fitted inside the chamber and on the support but is removable to permit a carrier to be placed on the support and thereafter clamped between the clamp member and the support, the clamp member having a plurality of holes arranged in a circle to receive a plurality of containers and being rotatable and arranged to rotate with it a carrier clamped between the clamp member and the support and wherein an external knob is provided to rotate the clamp member and an outlet mouthpiece leads substantially radiallyfrom the chamber.
4. A device as claimed in anyone of the preceding claims wherein the chamber has a cover which is removable to permit a carrier to be inserted in the chamber and placed on the support, the plunger being carried by the cover.
5. Adevice as claimed in claims 2 or3wherein the mouthpiece is enclosed in a removable mouthpiece cover, said mouthpiece cover having means for preventing operation of the plunger when the mouthpiece cover is fitted on the mouthpiece.
6. A device as claimed in anyone of the preceding claims wherein the carrier is a circular disc having a plurality of frangible containers arranged in a circle and containing a medicament in particulate form.
7. A device forthe administration of medicaments to a patient wherein a plurality of devices as claimed in any one of claims 1 to 5 is located in a common housing.
8. A device for administering medicaments to patients substantially as described with reference to any of the Figures of the accompanying drawings.
9. Two devices as claimed in anyone of the preceding claims located in a common housing.
10. A pack comprising a circular carrier disc provided with a plurality of containers arranged in a circle and each containing a dose of medicament in particulate form, the containers being openable to permitthe medicament therein to be released.
11. A packas claimed in claim 10wherein the containers are of generally conical form.
12. Apackas claimed in eitherof claims 10 orl 1 wherein the carrier disc is of foil laminate material.
13. Apackasclaimed in anyof claims 10- 12 wherein the medicaments are salbutamol and beclomethasone dipropionate in particulate form.
14. A packas claimed in anyone of claims 10- 12 wherein the medicament is sodium cromoglycate in particulate form.
15. Apackasclaimed in eitherof claims 13orl4in which the particle size of the medicament is substantially in the range 0.5 - 10 microns.
16. Apackasclaimed in anyone of claims 10 - 15 in which the medicament is admixed with a solid pharmaceutically acceptable carrier.
17. Apackas claimed in claim 16 in whichthe carrier is lactose.
Printed for Her Majesty's Stationery Office byTheTweeddale Press Ltd., Berwick-upon-Tweed, 1984. Published atthe Patent Office, 25 Southampton Buildings, London WC2A lAY, from which copies may be obtained.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI87002698A MY102120A (en) | 1983-05-24 | 1987-10-01 | Devices for administering medicaments to patients |
SG6989A SG6989G (en) | 1982-10-08 | 1989-02-09 | Medicament-containing pack |
KE386189A KE3861A (en) | 1982-10-08 | 1989-02-15 | Medicament-containing pack |
HK67689A HK67689A (en) | 1982-10-08 | 1989-08-24 | Medicament-containing pack |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8228887 | 1982-10-08 | ||
GB838314307A GB8314307D0 (en) | 1983-05-24 | 1983-05-24 | Medical administration devices |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8326878D0 GB8326878D0 (en) | 1983-11-09 |
GB2129691A true GB2129691A (en) | 1984-05-23 |
GB2129691B GB2129691B (en) | 1987-08-05 |
Family
ID=26284076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08326878A Expired GB2129691B (en) | 1982-10-08 | 1983-10-07 | Devices for administering medicaments to patients |
Country Status (30)
Country | Link |
---|---|
US (1) | US4627432A (en) |
JP (2) | JPH05200100A (en) |
KR (1) | KR910002248B1 (en) |
AT (1) | AT396333B (en) |
AU (2) | AU570013B2 (en) |
BR (1) | BR8305562A (en) |
CA (1) | CA1224992A (en) |
CH (1) | CH662277A5 (en) |
CY (2) | CY1478A (en) |
DE (1) | DE3336486A1 (en) |
DK (1) | DK172541B1 (en) |
ES (1) | ES286422Y (en) |
FI (1) | FI79651C (en) |
FR (2) | FR2550452B1 (en) |
GB (1) | GB2129691B (en) |
GR (1) | GR79615B (en) |
HK (1) | HK67789A (en) |
IE (1) | IE56059B1 (en) |
IL (1) | IL69932A (en) |
IN (1) | IN160851B (en) |
IT (1) | IT1203660B (en) |
KE (1) | KE3860A (en) |
LU (1) | LU85034A1 (en) |
NL (1) | NL192564C (en) |
NO (1) | NO160330C (en) |
NZ (1) | NZ205892A (en) |
PT (1) | PT77471B (en) |
SE (2) | SE458824B (en) |
SG (1) | SG6889G (en) |
ZW (1) | ZW21483A1 (en) |
Cited By (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2585563A1 (en) * | 1985-07-30 | 1987-02-06 | Glaxo Group Ltd | DEVICE FOR ADMINISTERING MEDICINES TO PATIENTS |
US4668218A (en) * | 1985-04-12 | 1987-05-26 | Aktiebolaget Draco | Indicating means for a dosage dispensing device |
DE4106379A1 (en) * | 1990-03-02 | 1991-09-05 | Glaxo Group Ltd | INHALATION DEVICE AND PACKAGE FOR THIS |
GB2246299A (en) * | 1990-06-08 | 1992-01-29 | Glaxo Group Ltd | Medicament-containing article and device therefor. |
GB2253200A (en) * | 1991-02-01 | 1992-09-02 | Harris Pharma Ltd | Inhalation apparatus and fracturable capsule for use therewith |
GB2264237A (en) * | 1992-02-05 | 1993-08-25 | Robert Edward Newell | An inhaler |
US5337740A (en) * | 1991-08-01 | 1994-08-16 | New England Pharmaceuticals, Inc. | Inhalation devices |
DE19500764A1 (en) * | 1995-01-13 | 1996-07-25 | Asta Medica Ag | Device for administering medication in airstream |
US5645050A (en) * | 1991-12-20 | 1997-07-08 | Boehringer Ingelheim Kg | Powder inhaler with powder carrier consisting of regular microstructures |
US5724959A (en) * | 1990-10-02 | 1998-03-10 | Aea Technology Plc | Powder inhaler with specific orifice and baffle arrangement |
US5881719A (en) * | 1995-06-30 | 1999-03-16 | Asta Medica Aktiengesellschaft | Inhaler for administering medicaments from blister packs |
EP1106196A2 (en) * | 1999-12-10 | 2001-06-13 | Unisia Jecs Corporation | Inhalant medicator |
WO2002012266A1 (en) | 2000-08-05 | 2002-02-14 | Glaxo Group Limited | 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
US6550477B1 (en) | 1995-08-02 | 2003-04-22 | Innovative Devices, Llc | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US6672304B1 (en) | 1995-06-08 | 2004-01-06 | Innovative Devices, Llc | Inhalation actuated device for use with metered dose inhalers (MDIs) |
EP1487524A1 (en) * | 2002-03-15 | 2004-12-22 | Valois, SAS | Dry powder inhaler |
WO2005046586A2 (en) | 2003-11-04 | 2005-05-26 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
WO2005104745A2 (en) | 2004-04-27 | 2005-11-10 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US7045658B2 (en) | 2001-03-22 | 2006-05-16 | Glaxo Group Limited | Formailide derivatives as beta2-adrenoreceptor agonists |
WO2006104889A2 (en) | 2005-03-25 | 2006-10-05 | Glaxo Group Limited | Novel compounds |
US7135600B2 (en) | 2001-02-14 | 2006-11-14 | Glaxo Group Limited | Phenethanolamine derivatives for treatment of respiratory diseases |
US7271197B2 (en) | 2002-04-25 | 2007-09-18 | Glaxo Group Limited | Phenethanolamine derivatives |
US7294650B2 (en) | 2003-12-17 | 2007-11-13 | Glaxo Group Limited | Benzothiophen and thiochrone containing phenethanolamine derivatives for the treatment of respiratory disorders |
US7318436B2 (en) | 2000-05-10 | 2008-01-15 | Innovative Devices, Llc | Medicament container with same side airflow inlet and outlet and method of use |
US7361787B2 (en) | 2001-09-14 | 2008-04-22 | Glaxo Group Limited | Phenethanolamine derivatives for treatment of respiratory diseases |
US7384946B2 (en) | 2004-03-17 | 2008-06-10 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
US7402598B2 (en) | 2002-07-25 | 2008-07-22 | Glaxo Group Limited | Arylethanolamine β2-adrenoreceptor agonist compounds |
WO2008118724A1 (en) | 2007-03-23 | 2008-10-02 | Smithkline Beecham Corporation | Indole carboxamides as ikk2 inhibitors |
US7442839B2 (en) | 2002-10-28 | 2008-10-28 | Glaxo Group Limited | Phenethanolamine derivative for the treatment of respiratory diseases |
US7495010B2 (en) | 2003-07-17 | 2009-02-24 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US7507747B2 (en) | 2003-10-17 | 2009-03-24 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
EP2039700A2 (en) | 2001-04-30 | 2009-03-25 | Glaxo Group Limited | Novel anti-inflammatory androstane derivatives |
US7538127B2 (en) | 2003-02-14 | 2009-05-26 | Glaxo Group Limited | Medicinal compounds |
US7576096B2 (en) | 2003-10-14 | 2009-08-18 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US7598267B2 (en) | 2004-05-13 | 2009-10-06 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US7767691B2 (en) | 2005-08-18 | 2010-08-03 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists containing an azoniabiocyclo[2.2.1] heptane ring system |
US7846973B2 (en) | 2004-04-02 | 2010-12-07 | Theravance, Inc. | Chemical process and new crystalline form |
WO2010147947A2 (en) | 2009-06-16 | 2010-12-23 | Schering Corporation | NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF |
US7956065B2 (en) | 2008-09-08 | 2011-06-07 | Biovail Laboratories International (Barbados) S.R.L. | Pharmaceutical compounds |
EP2363121A1 (en) | 2002-02-04 | 2011-09-07 | Glaxo Group Limited | Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions |
WO2012028662A1 (en) | 2010-08-31 | 2012-03-08 | Glaxo Group Limited | Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same |
WO2012028663A1 (en) | 2010-08-31 | 2012-03-08 | Glaxo Group Limited | Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same |
EP2436686A1 (en) | 2005-03-25 | 2012-04-04 | Glaxo Group Limited | Pyrimidopyridine compound used as a CSBP/RK/p38 modulator |
US8337816B2 (en) | 2001-09-17 | 2012-12-25 | Glaxo Group Limited | Dry powder medicament formulations |
WO2013045431A1 (en) | 2011-09-27 | 2013-04-04 | Glaxo Group Limited | Sulfonamide compounds and their use in the modulation retinoid - related orphan receptor |
US8434476B2 (en) | 2006-09-26 | 2013-05-07 | Alfred Von Schuckmann | Dispenser for pulverulent substances |
WO2013160418A1 (en) | 2012-04-27 | 2013-10-31 | Glaxo Group Limited | Novel compounds |
WO2013160419A1 (en) | 2012-04-27 | 2013-10-31 | Glaxo Group Limited | Novel compounds |
WO2014085474A1 (en) | 2012-11-28 | 2014-06-05 | Intercept Pharmaceuticals, Inc. | Treatment of pulmonary disease |
US9297813B2 (en) | 2010-11-11 | 2016-03-29 | Agency For Science, Technology And Research | Targeting metabolic enzymes in human cancer |
US9365905B2 (en) | 2005-02-10 | 2016-06-14 | Dmv-Fonterra Excipients Technology Gmbh | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
WO2016142426A1 (en) | 2015-03-11 | 2016-09-15 | Glaxosmithkline Intellectual Property Development Limited | Tslp binding proteins |
WO2016203400A1 (en) | 2015-06-15 | 2016-12-22 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 regulators |
WO2016203401A1 (en) | 2015-06-15 | 2016-12-22 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 regulators |
WO2017029602A2 (en) | 2015-08-16 | 2017-02-23 | Glaxosmithkline Intellectual Property Development Limited | Compounds for use in antibacterial applications |
WO2017060854A1 (en) | 2015-10-06 | 2017-04-13 | Glaxosmithkline Intellectual Property Development Limited | Biaryl pyrazoles as nrf2 regulators |
WO2017060855A1 (en) | 2015-10-06 | 2017-04-13 | Glaxosmithkline Intellectual Property Development Limited | Arylcyclohexyl pyrazoles as nrf2 regulators |
WO2018055527A1 (en) | 2016-09-20 | 2018-03-29 | Glaxosmithkline Intellectual Property (No.2) Limited | Trpv4 antagonists |
WO2018055526A1 (en) | 2016-09-20 | 2018-03-29 | Glaxosmithkline Intellectual Property (No.2) Limited | Trpv4 antagonists |
WO2018055524A1 (en) | 2016-09-20 | 2018-03-29 | Glaxosmithkline Intellectual Property (No.2) Limited | Trpv4 antagonists |
WO2018104766A1 (en) | 2016-12-06 | 2018-06-14 | Glaxosmithkline Intellectual Property Development Limited | 3-(2,3-dihydro-1h-inden-5-yl)propanoic acid derivatives and their use as nrf2 regulators |
WO2018109643A1 (en) | 2016-12-14 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Bisaryl heterocycles as nrf2 acti |
WO2018109641A1 (en) | 2016-12-12 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | 3-carboxylic acid pyrroles as nrf2 regulators |
WO2018109649A1 (en) | 2016-12-15 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Ether linked triazoles as nrf2 regulators |
WO2018109648A1 (en) | 2016-12-14 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | 3-oxo-1,4-diazepinyle compounds as nrf2 activators |
WO2018109642A1 (en) | 2016-12-12 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | N-aryl pyrazoles as nrf2 regulators |
WO2018109646A1 (en) | 2016-12-15 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 compounds |
WO2018109647A1 (en) | 2016-12-14 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Bisaryl amides as nrf2 regulators |
WO2018200425A1 (en) | 2017-04-24 | 2018-11-01 | Cocrystal Pharma, Inc. | Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication |
WO2019116230A1 (en) | 2017-12-11 | 2019-06-20 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome |
WO2019115640A1 (en) | 2017-12-15 | 2019-06-20 | Glaxosmithkline Intellectual Property Development Limited | 6-(morpholin-4-yl)-pyridin-2-yl-1h-pyrrolo[3,2-b]pyridine derivatives as m-tor inhibitors |
WO2019116231A1 (en) | 2017-12-11 | 2019-06-20 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome |
WO2019141694A1 (en) | 2018-01-17 | 2019-07-25 | Glaxosmithkline Intellectual Property Development Limited | Pi4kiiibeta inhibitors |
WO2019224667A1 (en) | 2018-05-23 | 2019-11-28 | Glaxosmithkline Intellectual Property Development Limited | Indanes as nrf2 activators |
WO2020023813A1 (en) | 2018-07-27 | 2020-01-30 | Cocrystal Pharma, Inc. | Pyrrolo[2,3-b]pyridin derivatives as inhibitors of influenza virus replication |
WO2020055858A1 (en) | 2018-09-10 | 2020-03-19 | Cocrystal Pharma, Inc. | Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication |
WO2020081751A1 (en) | 2018-10-17 | 2020-04-23 | Cocrystal Pharma, Inc. | Combinations of inhibitors of influenza virus replication |
WO2020102270A1 (en) | 2018-11-13 | 2020-05-22 | Cocrystal Pharma, Inc. | Formulations of influenza therapeutics |
WO2020112716A1 (en) | 2018-11-26 | 2020-06-04 | Cocrystal Pharma, Inc. | Inhibitors of influenza virus replication |
WO2020249652A1 (en) | 2019-06-13 | 2020-12-17 | Glaxosmithkline Intellectual Property Development Limited | Pyridyl or pyrimidyl mtor kinase inhibitors |
EP3782996A1 (en) | 2015-06-15 | 2021-02-24 | GlaxoSmithKline Intellectual Property Development Limited | Nrf2 regulators |
US11090294B2 (en) | 2009-12-01 | 2021-08-17 | Glaxo Group Limited | Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist |
US11116721B2 (en) | 2009-02-26 | 2021-09-14 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
WO2021188620A1 (en) | 2020-03-17 | 2021-09-23 | Cocrystal Pharma Inc. | Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication |
WO2021206876A1 (en) | 2020-04-10 | 2021-10-14 | Cocrystal Pharma, Inc. | Inhibitors of norovirus and coronavirus replication |
WO2021216547A1 (en) | 2020-04-20 | 2021-10-28 | Sorrento Therapeutics, Inc. | Pulmonary administration of ace2 polypeptides |
WO2022175425A1 (en) | 2021-02-22 | 2022-08-25 | Glaxosmithkline Intellectual Property Development Limited | Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection |
WO2022179967A1 (en) | 2021-02-23 | 2022-09-01 | Glaxosmithkline Intellectual Property (No.2) Limited | Vadadustat for treating covid-19 in a hospitalized subject |
WO2023014758A1 (en) | 2021-08-03 | 2023-02-09 | Cocrystal Pharma, Inc. | Inhibitors for coronaviruses |
Families Citing this family (302)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3348370C2 (en) * | 1982-10-08 | 2001-10-11 | Glaxo Group Ltd | Hand-held inhaler for powder or liq. medical inhalants |
SE8605130L (en) * | 1986-07-24 | 1988-01-25 | Marcus Diamant | TOOLS FOR CLIPPING TABLETS FROM TABLET CARDS AND SIMILAR |
US4817800A (en) * | 1987-05-20 | 1989-04-04 | Surgikos, Inc. | Fluid injection system cassette and fluid packaging methods |
FR2626500B1 (en) * | 1988-01-28 | 1990-04-27 | Valois Sa | VAPOR PUSH BUTTON AGENCY FOR MIXING AN ADDITIVE IN THE EMISSION OF THE JET |
CH678151A5 (en) * | 1988-07-13 | 1991-08-15 | Heinz Hermann Weick | Self-medication nasal dispenser |
GB8914223D0 (en) * | 1989-06-21 | 1989-08-09 | Fisons Plc | Medicament container |
US5239991A (en) * | 1989-06-21 | 1993-08-31 | Fisons Plc | Disposable powder medicament inhalation device with peel-off cover |
IT1230313B (en) * | 1989-07-07 | 1991-10-18 | Somova Spa | INHALER FOR CAPSULES MEDICATIONS. |
DE3927170A1 (en) * | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | INHALATOR |
US5009561A (en) * | 1989-08-18 | 1991-04-23 | Pharmacia Diagnostics Inc. | Reagent tablet dispenser |
US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
HU213221B (en) | 1990-03-02 | 1997-03-28 | Glaxo Group Ltd | Inhalation device and medicine packet for device |
MY105368A (en) * | 1990-03-02 | 1994-09-30 | Glaxo Group Ltd | Inhalation device. |
DE4021263C2 (en) * | 1990-07-04 | 1996-04-11 | Pfeiffer Erich Gmbh & Co Kg | Discharge device for media |
IT1243344B (en) * | 1990-07-16 | 1994-06-10 | Promo Pack Sa | MULTI-DOSE INHALER FOR POWDER MEDICATIONS |
FR2667509B1 (en) * | 1990-10-04 | 1995-08-25 | Valois | POWDER INHALER, DEVICE FOR PACKAGING POWDER MICRODOSES IN THE FORM OF BANDS SUITABLE FOR USE IN A POWDER INHALER, AND METHOD FOR MANUFACTURING SUCH BANDS. |
US5042472A (en) * | 1990-10-15 | 1991-08-27 | Merck & Co., Inc. | Powder inhaler device |
NL9002706A (en) * | 1990-12-10 | 1992-07-01 | Pharmachemie Bv | Apparatus for use when inhaling powdered materials packaged in rod capsules. |
US5243970A (en) * | 1991-04-15 | 1993-09-14 | Schering Corporation | Dosing device for administering metered amounts of powdered medicaments to patients |
US5327883A (en) * | 1991-05-20 | 1994-07-12 | Dura Pharmaceuticals, Inc. | Apparatus for aerosolizing powdered medicine and process and using |
US6681767B1 (en) | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
US5161524A (en) * | 1991-08-02 | 1992-11-10 | Glaxo Inc. | Dosage inhalator with air flow velocity regulating means |
GB9203761D0 (en) * | 1992-02-21 | 1992-04-08 | Innovata Biomed Ltd | Inhaler |
US5301664A (en) * | 1992-03-06 | 1994-04-12 | Sievers Robert E | Methods and apparatus for drug delivery using supercritical solutions |
US5394868A (en) * | 1992-06-25 | 1995-03-07 | Schering Corporation | Inhalation device for powdered medicaments |
US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US6509006B1 (en) | 1992-07-08 | 2003-01-21 | Inhale Therapeutic Systems, Inc. | Devices compositions and methods for the pulmonary delivery of aerosolized medicaments |
RO113214B1 (en) * | 1992-10-19 | 1998-05-29 | Dura Pharma Inc | Dry powder inhalator |
SE9203743D0 (en) * | 1992-12-11 | 1992-12-11 | Astra Ab | EFFICIENT USE |
US6250300B1 (en) | 1992-12-11 | 2001-06-26 | Ab Astra | System for dispensing pharmaceutically active compounds |
US5368187A (en) * | 1993-01-19 | 1994-11-29 | Poncetta; Stanley | Method and apparatus for dispensing materials from blister packages |
US5915378A (en) * | 1993-01-29 | 1999-06-29 | Aradigm Corporation | Creating an aerosolized formulation of insulin |
US5888477A (en) * | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
US5934272A (en) * | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
US5743250A (en) * | 1993-01-29 | 1998-04-28 | Aradigm Corporation | Insulin delivery enhanced by coached breathing |
US7448375B2 (en) | 1993-01-29 | 2008-11-11 | Aradigm Corporation | Method of treating diabetes mellitus in a patient |
US6024090A (en) | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
US5558085A (en) * | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
US5819726A (en) * | 1993-01-29 | 1998-10-13 | Aradigm Corporation | Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease |
US6098620A (en) * | 1993-01-29 | 2000-08-08 | Aradigm Corporation | Device for aerosolizing narcotics |
US6131567A (en) * | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US5970973A (en) * | 1993-01-29 | 1999-10-26 | Aradigm Corporation | Method of delivering insulin lispro |
US5724957A (en) * | 1993-01-29 | 1998-03-10 | Aradigm Corporation | Intrapulmonary delivery of narcotics |
US6012450A (en) * | 1993-01-29 | 2000-01-11 | Aradigm Corporation | Intrapulmonary delivery of hematopoietic drug |
US5672581A (en) * | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
US5873358A (en) * | 1993-01-29 | 1999-02-23 | Aradigm Corporation | Method of maintaining a diabetic patient's blood glucose level in a desired range |
NZ262807A (en) * | 1993-03-03 | 1997-11-24 | Glaxo Wellcome Inc | Inhalator; medicament carrier for dry powder inhalator has a portion with a plurality of interstices, for a predetermined dose |
TW360548B (en) | 1993-04-08 | 1999-06-11 | Powderject Res Ltd | Products for therapeutic use |
US5372128A (en) * | 1993-04-14 | 1994-12-13 | Habley Medical Technology Corporation | Fluidizing powder inhaler |
US5497763A (en) * | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
US5709202A (en) * | 1993-05-21 | 1998-01-20 | Aradigm Corporation | Intrapulmonary delivery of aerosolized formulations |
US5533502A (en) * | 1993-05-28 | 1996-07-09 | Vortran Medical Technology, Inc. | Powder inhaler with aerosolization occurring within each individual powder receptacle |
US5388572A (en) * | 1993-10-26 | 1995-02-14 | Tenax Corporation (A Connecticut Corp.) | Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same |
US5388573A (en) * | 1993-12-02 | 1995-02-14 | Tenax Corporation | Dry powder inhalator medicament carrier |
DK0748213T3 (en) | 1994-03-07 | 2004-08-02 | Nektar Therapeutics | Methods and compositions for pulmonary administration of insulin |
US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
US5664557A (en) * | 1994-03-10 | 1997-09-09 | Respiratory Delivery Systems, Inc. | Releasably engageable coupling for an inhaler |
US6102036A (en) * | 1994-04-12 | 2000-08-15 | Smoke-Stop | Breath activated inhaler |
GB9409851D0 (en) * | 1994-05-17 | 1994-07-06 | Cambridge Consultants | Improvements in and relating to containers of particulate material |
US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
EP0846009B1 (en) | 1994-09-21 | 2008-03-05 | Nektar Therapeutics | Apparatus and method for dispersing dry powder medicaments |
US5522385A (en) * | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
FR2725626A1 (en) * | 1994-10-18 | 1996-04-19 | Sofab | DEVICE FOR INHALING POWDERED PRODUCTS |
DE19502725B4 (en) * | 1995-01-28 | 2004-03-04 | Ing. Erich Pfeiffer Gmbh & Co Kg | Discharge device for media |
US5676643A (en) * | 1995-02-13 | 1997-10-14 | The Procter & Gamble Company | Dispenser for friably releasing dry particulate medicaments |
US5780014A (en) * | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
US5921237A (en) * | 1995-04-24 | 1999-07-13 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US5622166A (en) * | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
US5669973A (en) * | 1995-06-06 | 1997-09-23 | David Sarnoff Research Center, Inc. | Apparatus for electrostatically depositing and retaining materials upon a substrate |
US5714007A (en) | 1995-06-06 | 1998-02-03 | David Sarnoff Research Center, Inc. | Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
US20040237961A1 (en) * | 1995-06-08 | 2004-12-02 | Snow John Medlin | Inhalation actuated device for use with metered dose inhalers (MDIs) |
US5642727A (en) * | 1995-07-25 | 1997-07-01 | David Sarnoff Research Center, Inc. | Inhaler apparatus using a tribo-electric charging technique |
US5988163A (en) * | 1995-08-02 | 1999-11-23 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament |
US5692496A (en) * | 1995-08-02 | 1997-12-02 | Innovative Devices, Llc | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US5823183A (en) * | 1995-08-02 | 1998-10-20 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
NL1001031C1 (en) * | 1995-08-23 | 1997-02-25 | Npk Ind Design B V | Device for dispensing pills from a blister pack. |
US7131441B1 (en) | 1995-12-07 | 2006-11-07 | Skyepharma Ag | Inhaler for multiple dosed administration of a pharmacological dry powder |
ATE193455T1 (en) | 1995-12-07 | 2000-06-15 | Jago Pharma Ag | INHALER FOR THE MULTIPLE DOSE DELIVERY OF A PHARMACOLOGICAL DRY POWDER |
US5669378A (en) * | 1995-12-21 | 1997-09-23 | Pera; Ivo | Inhaling device |
US5823179A (en) | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
US5743251A (en) * | 1996-05-15 | 1998-04-28 | Philip Morris Incorporated | Aerosol and a method and apparatus for generating an aerosol |
US5871010A (en) | 1996-06-10 | 1999-02-16 | Sarnoff Corporation | Inhaler apparatus with modified surfaces for enhanced release of dry powders |
US5857456A (en) * | 1996-06-10 | 1999-01-12 | Sarnoff Corporation | Inhaler apparatus with an electronic means for enhanced release of dry powders |
JP2001507700A (en) | 1996-12-31 | 2001-06-12 | インヘイル・セラピューティック・システムズ | Hydrophobic aerosol drug |
US20030203036A1 (en) | 2000-03-17 | 2003-10-30 | Gordon Marc S. | Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients |
DE19704849B4 (en) * | 1997-02-08 | 2011-02-17 | Ing. Erich Pfeiffer Gmbh | Discharge device for media |
US6006747A (en) * | 1997-03-20 | 1999-12-28 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US5915560A (en) * | 1997-05-03 | 1999-06-29 | George; Donald C. | Compartmentalized pill dispenser |
US5909822A (en) * | 1997-05-03 | 1999-06-08 | George; Donald C. | Pill dispenser employing a sealed pill carrier |
US6116238A (en) * | 1997-12-02 | 2000-09-12 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
CN1301185A (en) | 1997-12-02 | 2001-06-27 | 杜兰药品公司 | Dry powder inhaler |
WO1999036115A2 (en) | 1998-01-16 | 1999-07-22 | 1263152 Ontario Inc. | Indicating device for use with a dispensing device |
WO1999047196A1 (en) | 1998-03-16 | 1999-09-23 | Inhale Therapeutic Systems, Inc. | Aerosolized active agent delivery |
US6082358A (en) | 1998-05-05 | 2000-07-04 | 1263152 Ontario Inc. | Indicating device for aerosol container |
US6729330B2 (en) | 1998-05-05 | 2004-05-04 | Trudell Medical International | Indicating device for aerosol container |
US6336453B1 (en) | 1999-04-30 | 2002-01-08 | Trudell Medical International | Indicating device for aerosol container |
US6257233B1 (en) * | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
US6149774A (en) | 1998-06-10 | 2000-11-21 | Delsys Pharmaceutical Corporation | AC waveforms biasing for bead manipulating chucks |
DE19831525A1 (en) * | 1998-07-14 | 2000-01-20 | Pfeiffer Erich Gmbh & Co Kg | Media Donor |
UA73924C2 (en) | 1998-10-09 | 2005-10-17 | Nektar Therapeutics | Device for delivering active agent formulation to lungs of human patient |
US6234167B1 (en) | 1998-10-14 | 2001-05-22 | Chrysalis Technologies, Incorporated | Aerosol generator and methods of making and using an aerosol generator |
US6923979B2 (en) * | 1999-04-27 | 2005-08-02 | Microdose Technologies, Inc. | Method for depositing particles onto a substrate using an alternating electric field |
IL146886A0 (en) | 1999-06-05 | 2002-08-14 | Innovata Biomed Ltd | Medicament delivery system |
US6606992B1 (en) | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
US6730066B1 (en) * | 1999-08-03 | 2004-05-04 | Pharmacia Ab | Liquid delivery container |
GB9920839D0 (en) * | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler |
US6679256B2 (en) | 1999-12-17 | 2004-01-20 | Nektar Therapeutics | Systems and methods for extracting powders from receptacles |
US6427688B1 (en) * | 2000-02-01 | 2002-08-06 | Dura Pharmaceuticals, Icn. | Dry powder inhaler |
US7089934B2 (en) | 2000-02-28 | 2006-08-15 | Vectura Limited | Delivery of oral drugs |
US6883516B2 (en) | 2000-04-27 | 2005-04-26 | Chrysalis Technologies Incorporated | Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution |
MY136453A (en) | 2000-04-27 | 2008-10-31 | Philip Morris Usa Inc | "improved method and apparatus for generating an aerosol" |
GB0015034D0 (en) * | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Inhalation device |
TWI224515B (en) * | 2000-06-23 | 2004-12-01 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
US7575761B2 (en) | 2000-06-30 | 2009-08-18 | Novartis Pharma Ag | Spray drying process control of drying kinetics |
US6948492B2 (en) * | 2000-08-15 | 2005-09-27 | University Of Kentucky Research Foundation | Programmable multi-dose intranasal drug delivery device |
US6681998B2 (en) | 2000-12-22 | 2004-01-27 | Chrysalis Technologies Incorporated | Aerosol generator having inductive heater and method of use thereof |
US6491233B2 (en) | 2000-12-22 | 2002-12-10 | Chrysalis Technologies Incorporated | Vapor driven aerosol generator and method of use thereof |
US6799572B2 (en) | 2000-12-22 | 2004-10-05 | Chrysalis Technologies Incorporated | Disposable aerosol generator system and methods for administering the aerosol |
US7077130B2 (en) | 2000-12-22 | 2006-07-18 | Chrysalis Technologies Incorporated | Disposable inhaler system |
US6501052B2 (en) | 2000-12-22 | 2002-12-31 | Chrysalis Technologies Incorporated | Aerosol generator having multiple heating zones and methods of use thereof |
US6701921B2 (en) | 2000-12-22 | 2004-03-09 | Chrysalis Technologies Incorporated | Aerosol generator having heater in multilayered composite and method of use thereof |
EP1370315B1 (en) | 2001-03-20 | 2011-11-09 | Trudell Medical International | Nebulizer apparatus |
US6745760B2 (en) | 2001-05-15 | 2004-06-08 | Trudell Medical International | Medicament applicator |
US8061006B2 (en) | 2001-07-26 | 2011-11-22 | Powderject Research Limited | Particle cassette, method and kit therefor |
US7176278B2 (en) | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
WO2003024514A1 (en) | 2001-09-19 | 2003-03-27 | Advent Pharmaceuticals Pty Ltd | An inhaler |
US6640050B2 (en) | 2001-09-21 | 2003-10-28 | Chrysalis Technologies Incorporated | Fluid vaporizing device having controlled temperature profile heater/capillary tube |
US6568390B2 (en) | 2001-09-21 | 2003-05-27 | Chrysalis Technologies Incorporated | Dual capillary fluid vaporizing device |
US7931022B2 (en) * | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
GB0128148D0 (en) | 2001-11-23 | 2002-01-16 | Innovata Biomed Ltd | Assembly |
US6804458B2 (en) * | 2001-12-06 | 2004-10-12 | Chrysalis Technologies Incorporated | Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate |
US6681769B2 (en) | 2001-12-06 | 2004-01-27 | Crysalis Technologies Incorporated | Aerosol generator having a multiple path heater arrangement and method of use thereof |
US6701922B2 (en) | 2001-12-20 | 2004-03-09 | Chrysalis Technologies Incorporated | Mouthpiece entrainment airflow control for aerosol generators |
US7458373B2 (en) * | 2002-01-15 | 2008-12-02 | Philip Morris Usa Inc. | Aerosol generator for drug formulation |
GB0201677D0 (en) * | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
GB0217199D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
EP1507583A1 (en) * | 2002-03-01 | 2005-02-23 | Glaxo Group Limited | Rotary blending apparatus and system |
US7794965B2 (en) | 2002-03-13 | 2010-09-14 | Signum Biosciences, Inc. | Method of identifying modulators of PP2A methylase |
US7004164B2 (en) | 2002-03-21 | 2006-02-28 | Trudell Medical International | Indicating device for aerosol container |
JP2006504446A (en) * | 2002-03-26 | 2006-02-09 | グラクソ グループ リミテッド | Method for forming laminate assembly and product formed thereby |
US20030235538A1 (en) * | 2002-04-09 | 2003-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method for the administration of an anticholinergic by inhalation |
UA80123C2 (en) * | 2002-04-09 | 2007-08-27 | Boehringer Ingelheim Pharma | Inhalation kit comprising inhalable powder of tiotropium |
DE10217929A1 (en) * | 2002-04-22 | 2003-11-06 | Sixp Ag | Device for dispensing tablets |
GB0216562D0 (en) | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
AU2003228683A1 (en) * | 2002-04-25 | 2003-11-10 | Glaxo Group Limited | Magnetoacoustic sensor system and associated method for sensing environmental conditions |
GB2388040B (en) * | 2002-05-02 | 2005-12-14 | Robert Jeremy West | Nicotine inhalation device |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
US6854461B2 (en) * | 2002-05-10 | 2005-02-15 | Philip Morris Usa Inc. | Aerosol generator for drug formulation and methods of generating aerosol |
US7089786B2 (en) * | 2002-05-15 | 2006-08-15 | Glaxo Group Limited | Microelectromechanical system and method for determining temperature and moisture profiles within pharmaceutical packaging |
US6904908B2 (en) | 2002-05-21 | 2005-06-14 | Trudell Medical International | Visual indicator for an aerosol medication delivery apparatus and system |
US7185651B2 (en) | 2002-06-18 | 2007-03-06 | Nektar Therapeutics | Flow regulator for aerosol drug delivery and methods |
EP1534367A1 (en) * | 2002-07-25 | 2005-06-01 | Glaxo Group Limited | Medicament dispenser |
GB0217196D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
JP2005533582A (en) * | 2002-07-25 | 2005-11-10 | グラクソ グループ リミテッド | Drug dispenser |
GB0217198D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
AU2003270321B2 (en) * | 2002-09-06 | 2008-04-03 | Philip Morris Products S.A. | Aerosol generating devices and methods for generating aerosols having controlled particle sizes |
US20070139442A1 (en) * | 2002-09-13 | 2007-06-21 | Robinson Karl E | Coated blending system |
US6772757B2 (en) | 2002-10-25 | 2004-08-10 | Chrysalis Technologies Incorporated | Concentric controlled temperature profile fluid vaporizing device |
WO2004060260A2 (en) * | 2002-12-18 | 2004-07-22 | Glaxo Group Limited | Drug delivery system with vented mouthpiece |
US20040173211A1 (en) * | 2003-01-14 | 2004-09-09 | Boehringer Ingelheim International Gmbh | Powder inhaler |
GB2420774B (en) * | 2003-02-05 | 2006-11-08 | Martin John Tedham | Dispenser |
DE10317461A1 (en) | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt |
EP1488819A1 (en) * | 2003-06-16 | 2004-12-22 | Rijksuniversiteit te Groningen | Dry powder inhaler and method for pulmonary inhalation of dry powder |
GB0315509D0 (en) * | 2003-07-02 | 2003-08-06 | Meridica Ltd | Dispensing device |
US7367334B2 (en) | 2003-08-27 | 2008-05-06 | Philip Morris Usa Inc. | Fluid vaporizing device having controlled temperature profile heater/capillary tube |
US20070277820A1 (en) * | 2003-10-27 | 2007-12-06 | Timothy Crowder | Blister packages and associated methods of fabricating dry powder drug containment systems |
US7621273B2 (en) | 2003-10-28 | 2009-11-24 | Trudell Medical International | Indicating device with warning dosage indicator |
SE0303570L (en) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Moisture-sensitive medical product |
SE0303270L (en) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Method of administration of tiotropium |
WO2005053647A1 (en) * | 2003-12-03 | 2005-06-16 | Microdrug Ag | Medical product containing tiotropium |
US7100530B2 (en) | 2003-12-15 | 2006-09-05 | Trudell Medical International, Inc. | Dose indicating device |
US8147426B2 (en) * | 2003-12-31 | 2012-04-03 | Nipro Diagnostics, Inc. | Integrated diagnostic test system |
CA2562386C (en) | 2004-04-21 | 2014-11-18 | Innovata Biomed Limited | Inhaler |
GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
GB0418738D0 (en) * | 2004-08-23 | 2004-09-22 | 3M Innovative Properties Co | Medicinal aerosol formulation receptacle and production thereof |
US7543582B2 (en) | 2004-09-20 | 2009-06-09 | Trudell Medical International | Dose indicating device with display elements attached to container |
MX2007004768A (en) * | 2004-10-21 | 2007-05-10 | Boehringer Ingelheim Int | Blister for inhalers. |
US8165460B2 (en) * | 2004-10-26 | 2012-04-24 | The University Of North Carolina At Chapel Hill | Coated filament for evaporation/condensation aerosol generation of therapeutic agents and methods for using |
JP2006130143A (en) * | 2004-11-08 | 2006-05-25 | Hitachi Ltd | Inhalation administration device and medicine cartridge |
EP1812778A2 (en) * | 2004-11-12 | 2007-08-01 | Glaxo Group Limited | Sensor system with acoustic transducer |
CN101810901B (en) | 2005-01-20 | 2013-07-24 | 特鲁德尔医学国际公司 | Dispensing device |
WO2006084033A1 (en) | 2005-02-03 | 2006-08-10 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
GB0507711D0 (en) | 2005-04-15 | 2005-05-25 | Vectura Group Plc | Improved blister piercing |
US9345745B2 (en) | 2005-04-29 | 2016-05-24 | Bo Wang | Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides |
US9585932B2 (en) | 2005-04-29 | 2017-03-07 | Peter C. Dowling | Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders |
US8653028B2 (en) * | 2005-04-29 | 2014-02-18 | Rui Rong Yuan | Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
US20090042843A1 (en) * | 2005-05-04 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Inhalation Device Containing Plural Doses of a Pharmaceutical Composition |
DE102005035705A1 (en) * | 2005-07-27 | 2007-02-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | pharmaceutical blister |
US20090192227A1 (en) * | 2005-08-24 | 2009-07-30 | Rabindra Tirouvanziam | N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease |
WO2007024876A2 (en) * | 2005-08-24 | 2007-03-01 | The Board Of Trustees Of Leland Stanford Junior University | Methods for treating and monitoring inflammation and redox imbalance in cystic fibrosis |
TWI274641B (en) * | 2005-08-30 | 2007-03-01 | Rexon Ind Corp Ltd | Cutting machine |
US8227408B2 (en) * | 2005-09-07 | 2012-07-24 | Neurotez, Inc. | Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology |
US20130131007A1 (en) | 2005-09-07 | 2013-05-23 | Bebaas, Inc. | Vitamin b12 compositions |
US20070178141A1 (en) * | 2005-09-07 | 2007-08-02 | Bebaas, Inc. | Vitamin B12 compositions |
US8642543B2 (en) * | 2005-09-07 | 2014-02-04 | Neurotez, Inc. | Methods for treating progressive cognitive disorders related to neurofibrillary tangles |
US9107824B2 (en) | 2005-11-08 | 2015-08-18 | Insmed Incorporated | Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally |
EP1795221A1 (en) * | 2005-12-02 | 2007-06-13 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
US8037880B2 (en) * | 2006-04-07 | 2011-10-18 | The University Of Western Ontario | Dry powder inhaler |
EP1844808A1 (en) * | 2006-04-13 | 2007-10-17 | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG | Medicament delivery device |
EP1844809A1 (en) * | 2006-04-13 | 2007-10-17 | Boehringer Ingelheim Pharma GmbH & Co. KG | Container for inhaler, and multidose inhaler |
DE102006043637A1 (en) * | 2006-05-18 | 2007-11-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | atomizer |
DE102006023662A1 (en) * | 2006-05-18 | 2007-11-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | inhaler |
US9457161B2 (en) | 2006-05-18 | 2016-10-04 | Boehringer Ingelheim International Gmbh | Inhaler |
US8141550B2 (en) | 2006-08-01 | 2012-03-27 | Trudell Medical International | Dispensing device |
MX2009001944A (en) | 2006-08-21 | 2009-04-16 | Trudell Medical Int | Respiratory muscle endurance training device and method for the use thereof. |
US8573197B2 (en) | 2006-10-25 | 2013-11-05 | Novartis Ag | Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices |
GB0621957D0 (en) * | 2006-11-03 | 2006-12-13 | Vectura Group Plc | Inhaler devices and bespoke pharmaceutical compositions |
EP1925295A1 (en) | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stable powder formulation containing a new antichinolinergic agent |
BRPI0806474A2 (en) | 2007-01-09 | 2011-09-27 | Mystic Pharmaceuticals Inc | intranasal cartridge devices |
EP2617431B1 (en) | 2007-01-10 | 2017-04-12 | Purdue Research Foundation | Polypeptide inhibitors of HSP27 kinase and uses therefor |
US9248076B2 (en) | 2007-05-16 | 2016-02-02 | Mystic Pharmaceuticals, Inc. | Dose dispensing containers |
EP1992380A1 (en) | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
EP1992377A1 (en) * | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
EP1992376A1 (en) | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
EP1992378A1 (en) * | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
EP1992373A1 (en) | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
EP1992379A1 (en) * | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
EP1992374A1 (en) * | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
EP1992372A1 (en) | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
PE20090136A1 (en) * | 2007-06-01 | 2009-03-11 | Boehringer Ingelheim Int | DISPENSING DEVICE |
AT505246B8 (en) * | 2007-06-01 | 2009-06-15 | Croma Pharma Gmbh | CONTAINER FOR A MULTIPLE OF INDIVIDUAL CANS AND APPLICATOR FOR SUCH CONTAINERS |
DK2185698T3 (en) * | 2007-08-07 | 2015-07-27 | Purdue Research Foundation | Kinase Inhibitors and Uses thereof |
EP2042208A1 (en) * | 2007-09-25 | 2009-04-01 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
EP2082763A1 (en) * | 2008-01-24 | 2009-07-29 | Boehringer Ingelheim International Gmbh | Inhaler |
US20110203586A1 (en) * | 2008-02-20 | 2011-08-25 | Boehringer Ingelheim International Gmbh | Powder Inhalers |
WO2009105515A2 (en) | 2008-02-21 | 2009-08-27 | Trudell Medical International | Respiratory muscle endurance training device and method for the use thereof |
US20090235929A1 (en) * | 2008-03-19 | 2009-09-24 | Marc Egen | Powder inhalers |
US8082873B2 (en) | 2008-05-05 | 2011-12-27 | Trudell Medical International | Drive mechanism for an indicating device |
US8181591B1 (en) | 2008-05-23 | 2012-05-22 | Trudell Medical International | Domed actuator for indicating device |
JP5470393B2 (en) | 2008-09-26 | 2014-04-16 | オリエル・セラピューティクス,インコーポレイテッド | Dry powder inhaler |
ES2550309T3 (en) * | 2008-09-26 | 2015-11-06 | Oriel Therapeutics, Inc. | Inhaler mechanisms with radially predisposed perforators and related methods |
AU2009296538B8 (en) | 2008-09-26 | 2013-06-27 | Oriel Therapeutics, Inc. | Inhalers with airway disks having discrete airway channels and related disks and methods |
WO2010039201A2 (en) * | 2008-09-30 | 2010-04-08 | Oriel Therapeutics, Inc. | Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods |
US8646446B2 (en) * | 2008-10-01 | 2014-02-11 | Oriel Therapeutics, Inc. | Dry powder inhalers with rotating piercing mechanisms and related devices and methods |
NZ591854A (en) * | 2008-10-08 | 2013-07-26 | Astrazeneca Ab | Inhaler with audible indicator means and sound disabler |
BRPI0919759A2 (en) * | 2008-10-20 | 2017-03-21 | Moerae Matrix Inc | adhesion treatment and prevention polypeptides |
EP2179760B1 (en) | 2008-10-22 | 2013-02-27 | Trudell Medical International | Modular Aerosol Delivery System |
CA2742600A1 (en) * | 2008-11-04 | 2010-05-14 | Nikolaos Tezapsidis | Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta |
US8919341B2 (en) * | 2008-12-03 | 2014-12-30 | Boehringer Ingelheim International Gmbh | Inhaler |
WO2010068692A1 (en) * | 2008-12-10 | 2010-06-17 | Purdue Research Foundation | Cell-permeant peptide-based inhibitor of kinases |
GB0901520D0 (en) | 2009-01-30 | 2009-03-11 | Vectura Delivery Devices Ltd | Inhaler |
WO2010105776A1 (en) | 2009-03-17 | 2010-09-23 | Boehringer Ingelheim International Gmbh | Dispensing device, storage device and method for dispensing a formulation |
EP2432536B1 (en) * | 2009-05-21 | 2018-07-04 | MicroDose Therapeutx, Inc. | Rotary cassette system for dry powder inhaler |
US8985101B2 (en) | 2009-05-21 | 2015-03-24 | Microdose Therapeutx, Inc. | Method and device for clamping a blister within a dry powder inhaler |
MX364173B (en) | 2009-07-24 | 2019-04-15 | Amazentis Sa Star | Compounds, compositions and methods for protecting brain health in neurodegenerative disorders. |
US9890195B2 (en) * | 2009-07-27 | 2018-02-13 | Purdue Research Foundation | MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
CN104338219B (en) | 2010-01-05 | 2017-10-24 | 微剂量治疗技术公司 | inhalation device and method |
US8135497B2 (en) | 2010-01-13 | 2012-03-13 | Joslyn Matthew I | Portable, personal medication dispensing apparatus and method |
CN103002854B (en) | 2010-03-18 | 2015-01-21 | 麦德康股份有限公司 | A disposable rigid container for pharmaceutical compositions |
USD641076S1 (en) | 2010-03-26 | 2011-07-05 | Oriel Therapeutics, Inc. | Dry powder inhaler |
USD635246S1 (en) | 2010-03-26 | 2011-03-29 | Oriel Therapeutics, Inc. | Dose disk for dry powder inhalers |
USD666096S1 (en) | 2010-11-01 | 2012-08-28 | Colgate-Palmolive Company | Cap for a container |
USD666492S1 (en) | 2010-11-01 | 2012-09-04 | Colgate-Palmolive Company | Cap for a container |
USD666099S1 (en) | 2010-11-01 | 2012-08-28 | Colgate-Palmolive Company | Cap for a container |
USD666097S1 (en) | 2010-11-01 | 2012-08-28 | Colgate-Palmolive Company | Cap for a container |
USD666098S1 (en) | 2010-11-01 | 2012-08-28 | Colgate-Palmolive Company | Cap for a container |
USD666493S1 (en) | 2010-11-01 | 2012-09-04 | Colgate-Palmolive Company | Cap for a container |
BR112013026313A8 (en) | 2011-04-12 | 2018-01-30 | Moerae Matrix Inc | compositions and methods for preventing or treating diseases, conditions or processes characterized by abnormal fibroblast proliferation and extracellular matrix deposition |
US9890200B2 (en) | 2011-04-12 | 2018-02-13 | Moerae Matrix, Inc. | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
CA2981038C (en) | 2011-05-19 | 2018-09-25 | Savara Inc. | Dry powder vancomycin compositions and associated methods |
US8585659B2 (en) * | 2011-05-31 | 2013-11-19 | Mystic Pharmaceuticals, Inc. | Piercing device for drug delivery systems |
EP2589381B1 (en) | 2011-11-04 | 2016-08-31 | Rabindra Tirouvanziam | Compositions for improving or preserving lung function in a patient with a pulmonary disorder |
WO2013134636A1 (en) | 2012-03-09 | 2013-09-12 | Purdue Research Foundation | Compositions and methods for delivery of kinase inhibiting peptides |
DK2892524T3 (en) | 2012-09-04 | 2021-01-25 | Eleison Pharmaceuticals LLC | PREVENTION OF PULMONAL CANCER RECYCLING WITH LIPID-COMPLEXED CISPLATIN |
GB201301192D0 (en) | 2013-01-23 | 2013-03-06 | Vectura Delivery Devices Ltd | A blister piercing element for a dry powder inhaler |
JP2015037466A (en) * | 2013-04-08 | 2015-02-26 | ニップファーマ株式会社 | Medicament inhalation device |
MX2016003082A (en) | 2013-09-10 | 2016-09-13 | Univ Texas | Therapeutics targeting truncated adenomatous polyposis coli (apc) proteins. |
US10149951B2 (en) | 2013-10-15 | 2018-12-11 | Mystic Pharmaceuticals, Inc. | Controllable rate turbulating nozzle |
US10336788B2 (en) | 2014-04-17 | 2019-07-02 | Moerae Matrix, Inc. | Inhibition of cardiac fibrosis in myocardial infarction |
WO2015164142A1 (en) * | 2014-04-24 | 2015-10-29 | Questa Corporation | Multi-size pill splitter and methods |
CA2948441A1 (en) | 2014-05-12 | 2015-11-19 | Glaxosmithkline Intellectual Property (No. 2) Limited | Pharmaceutical compositions for treating infectious diseases |
US10082496B2 (en) | 2014-09-10 | 2018-09-25 | Board Of Regents Of The University Of Texas System | Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis |
CN107106641B (en) | 2014-10-31 | 2021-12-21 | 葛兰素史密斯克莱知识产权发展有限公司 | Powder formulation |
BR112017010238A2 (en) | 2014-11-17 | 2018-02-06 | Moerae Matrix, Inc. | compositions and methods for preventing or treating diseases, conditions or processes characterized by fibroblast proliferation and aberrant extracellular matrix deposition |
EP3229831B1 (en) | 2014-12-10 | 2020-03-11 | Hyperstem SA | Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors |
USD754919S1 (en) * | 2014-12-19 | 2016-04-26 | Fontem Holdings 4 B.V. | Mouthpiece |
JP2018502860A (en) | 2015-01-08 | 2018-02-01 | モイライ マトリックス インコーポレイテッド | MK2 inhibitory peptide preparation |
US10314766B2 (en) | 2015-01-21 | 2019-06-11 | Mylan, Inc. | Medication packaging and dose regimen system |
MX2017011633A (en) | 2015-03-12 | 2017-11-02 | Moerae Matrix Inc | Use of mk2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with same. |
CA2986797A1 (en) * | 2015-05-22 | 2016-12-01 | Compressed Perforated Puck Technologies Inc. | Vaporizer apparatus for compressed tablet and loose fill plant source materials |
EP3307069B1 (en) | 2015-06-10 | 2021-08-04 | Hackensack University Medical Center | Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases |
CN107949279A (en) | 2015-07-06 | 2018-04-20 | 得克萨斯系统大学评议会 | It can be used as the benzamide or benzamine compound of the anticancer for treating human cancer |
WO2017011215A1 (en) | 2015-07-15 | 2017-01-19 | The Board Of Regents Of The University Of Texas System | Targeting emopamil binding protein (ebp) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis |
JP2018535984A (en) | 2015-11-18 | 2018-12-06 | グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited | Ribavirin pharmaceutical composition |
US11833118B2 (en) | 2016-01-20 | 2023-12-05 | Flurry Powders, Llc | Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation |
EP3405175A4 (en) | 2016-01-20 | 2019-09-25 | Flurry Powders, LLC | Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation |
US10850050B2 (en) | 2016-05-19 | 2020-12-01 | Trudell Medical International | Smart valved holding chamber |
US10786638B2 (en) | 2016-07-08 | 2020-09-29 | Trudell Medical International | Nebulizer apparatus and method |
ES2894895T3 (en) | 2016-07-08 | 2022-02-16 | Trudell Medical Int | Intelligent oscillating positive expiratory pressure device |
EP3551261B1 (en) | 2016-12-09 | 2022-05-11 | Trudell Medical International | Smart nebulizer |
MX2020007026A (en) | 2018-01-04 | 2020-12-03 | Trudell Medical Int | Smart oscillating positive expiratory pressure device. |
CN108815653B (en) * | 2018-04-19 | 2020-11-10 | 山西白求恩医院 | Atomizer with adjustable gas velocity |
GB201812671D0 (en) | 2018-08-03 | 2018-09-19 | Coalesce Product Dev Ltd | An inhaler device |
DE102019134285A1 (en) | 2019-01-15 | 2020-07-16 | Nuuvera Deutschland GmbH | Device and method for extracting and aspirating active substances, in particular from the cannabis plant |
CN109939309B (en) * | 2019-04-01 | 2021-06-01 | 中国科学院大学深圳医院(光明) | Powder inhalation device |
CA3152072A1 (en) | 2019-08-27 | 2021-03-04 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
CN112298819A (en) * | 2020-10-28 | 2021-02-02 | 朱爱庆 | Quantitative medicine taking bottle with moisture-proof function |
US11517704B1 (en) * | 2021-12-06 | 2022-12-06 | Stat Capsule Inc. | Wristband capsule crusher |
CN114098624B (en) * | 2021-12-30 | 2022-09-02 | 山东第一医科大学附属省立医院(山东省立医院) | Visual quick internal examination device for rectum |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1387954A (en) * | 1973-05-08 | 1975-03-19 | Miles Lab | Insufflator |
GB1526303A (en) * | 1974-08-22 | 1978-09-27 | Schering Ag | Device for the inhalation of medicaments |
GB2061735A (en) * | 1979-10-30 | 1981-05-20 | Riker Laboratories Inc | Breath actuated device for administration of powdered medicaments by inhalation |
GB1603186A (en) * | 1977-04-07 | 1981-11-18 | Schering Ag | Device for the inhalation of medicaments |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB516834A (en) * | 1937-12-23 | 1940-01-12 | Charles Alexandre Nicolle | Improvements in or relating to packaging |
CH385718A (en) * | 1961-11-04 | 1964-12-15 | Bodet Jean | Method and device for packaging solid articles of small volume, and assembly obtained by this method |
CH411232A (en) * | 1963-11-12 | 1966-04-15 | Ciba Geigy | Drug packaging |
GB1268051A (en) * | 1968-06-07 | 1972-03-22 | Fisons Pharmaceuticals Ltd | Inhalation device |
DE2321615A1 (en) * | 1973-04-28 | 1974-11-14 | Aluminium Walzwerke Singen | Child proof blister packaging for e.g. medicines - has selectively perforated cover plate through which medicines are pushed |
US4015717A (en) * | 1974-03-29 | 1977-04-05 | The Medical Dispenser Company | Tablet package for use in chronologically dispensing tablets |
AT337088B (en) * | 1975-05-20 | 1977-06-10 | Desinfecta Ges M B H | PACKAGING FOR POWDER, GRAIN AND THE LIKE. AND METHOD OF MANUFACTURING IT |
GB1562732A (en) * | 1976-02-10 | 1980-03-12 | Allen & Hanburys Ltd | Device for dispensing medicaments |
DE2835122C3 (en) * | 1978-08-10 | 1982-02-18 | Bosch-Siemens Hausgeräte GmbH, 7000 Stuttgart | Inhalation device |
CY1308A (en) * | 1979-12-06 | 1985-12-06 | Glaxo Group Ltd | Device for dispensing medicaments |
BR8007911A (en) * | 1979-12-06 | 1981-06-16 | Glaxo Group Ltd | PERFECTED INHALER |
US4307734A (en) * | 1980-06-23 | 1981-12-29 | B & B Inventors & Marketers, Inc. | Snuff dispenser |
ES8206980A1 (en) * | 1980-10-30 | 1982-09-01 | Riker Laboratories Inc | Powder inhalation device. |
DE8218231U1 (en) * | 1982-06-25 | 1982-12-30 | Karl Knauer Gmbh & Co Kg, 7616 Biberach | Display pack, especially blister pack |
-
1983
- 1983-10-07 LU LU85034A patent/LU85034A1/en unknown
- 1983-10-07 CA CA000438678A patent/CA1224992A/en not_active Expired
- 1983-10-07 AT AT0357683A patent/AT396333B/en not_active IP Right Cessation
- 1983-10-07 ZW ZW214/83A patent/ZW21483A1/en unknown
- 1983-10-07 DK DK198304643A patent/DK172541B1/en not_active IP Right Cessation
- 1983-10-07 SE SE8305542A patent/SE458824B/en not_active IP Right Cessation
- 1983-10-07 CH CH5469/83A patent/CH662277A5/en not_active IP Right Cessation
- 1983-10-07 GR GR72643A patent/GR79615B/el unknown
- 1983-10-07 NZ NZ205892A patent/NZ205892A/en unknown
- 1983-10-07 FI FI833641A patent/FI79651C/en not_active IP Right Cessation
- 1983-10-07 PT PT77471A patent/PT77471B/en unknown
- 1983-10-07 NL NL8303461A patent/NL192564C/en not_active IP Right Cessation
- 1983-10-07 IE IE2367/83A patent/IE56059B1/en not_active IP Right Cessation
- 1983-10-07 GB GB08326878A patent/GB2129691B/en not_active Expired
- 1983-10-07 ES ES1983286422U patent/ES286422Y/en not_active Expired
- 1983-10-07 IN IN1243/CAL/83A patent/IN160851B/en unknown
- 1983-10-07 IL IL69932A patent/IL69932A/en not_active IP Right Cessation
- 1983-10-07 FR FR838316025A patent/FR2550452B1/en not_active Expired - Lifetime
- 1983-10-07 BR BR8305562A patent/BR8305562A/en not_active IP Right Cessation
- 1983-10-07 US US06/540,203 patent/US4627432A/en not_active Expired - Lifetime
- 1983-10-07 AU AU19977/83A patent/AU570013B2/en not_active Expired
- 1983-10-07 NO NO833667A patent/NO160330C/en not_active IP Right Cessation
- 1983-10-07 IT IT49120/83A patent/IT1203660B/en active
- 1983-10-07 DE DE19833336486 patent/DE3336486A1/en active Granted
- 1983-10-08 KR KR1019830004771A patent/KR910002248B1/en not_active IP Right Cessation
-
1985
- 1985-03-25 FR FR858504382A patent/FR2570607B1/en not_active Expired - Lifetime
-
1987
- 1987-12-30 AU AU83155/87A patent/AU584535B2/en not_active Expired
-
1988
- 1988-10-17 SE SE8803702A patent/SE465752B/en not_active IP Right Cessation
-
1989
- 1989-02-09 SG SG68/89A patent/SG6889G/en unknown
- 1989-02-15 KE KE3860A patent/KE3860A/en unknown
- 1989-07-21 CY CY1478A patent/CY1478A/en unknown
- 1989-07-21 CY CY1477A patent/CY1477A/en unknown
- 1989-08-24 HK HK677/89A patent/HK67789A/en not_active IP Right Cessation
-
1991
- 1991-09-26 JP JP3274575A patent/JPH05200100A/en active Granted
-
1992
- 1992-03-23 JP JP1992015218U patent/JPH0620532Y2/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1387954A (en) * | 1973-05-08 | 1975-03-19 | Miles Lab | Insufflator |
GB1526303A (en) * | 1974-08-22 | 1978-09-27 | Schering Ag | Device for the inhalation of medicaments |
GB1603186A (en) * | 1977-04-07 | 1981-11-18 | Schering Ag | Device for the inhalation of medicaments |
GB2061735A (en) * | 1979-10-30 | 1981-05-20 | Riker Laboratories Inc | Breath actuated device for administration of powdered medicaments by inhalation |
Cited By (138)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4668218A (en) * | 1985-04-12 | 1987-05-26 | Aktiebolaget Draco | Indicating means for a dosage dispensing device |
EP0211595A2 (en) * | 1985-07-30 | 1987-02-25 | Glaxo Group Limited | Devices for administering medicaments to patients |
DE3625685A1 (en) * | 1985-07-30 | 1987-03-12 | Glaxo Group Ltd | DEVICE FOR INPUTING MEDICATIONS |
EP0211595A3 (en) * | 1985-07-30 | 1988-10-05 | Glaxo Group Limited | Devices for administering medicaments to patients |
FR2585563A1 (en) * | 1985-07-30 | 1987-02-06 | Glaxo Group Ltd | DEVICE FOR ADMINISTERING MEDICINES TO PATIENTS |
AT396872B (en) * | 1985-07-30 | 1993-12-27 | Glaxo Group Ltd | DEVICE FOR ADMINISTERING MEDICINES IN POWDER FORM |
US5590645A (en) * | 1990-03-02 | 1997-01-07 | Glaxo Group Limited | Inhalation device |
DE4106379A1 (en) * | 1990-03-02 | 1991-09-05 | Glaxo Group Ltd | INHALATION DEVICE AND PACKAGE FOR THIS |
US6032666A (en) * | 1990-03-02 | 2000-03-07 | Glaxo Group Limited | Inhalation device |
US5873360A (en) * | 1990-03-02 | 1999-02-23 | Glaxo Group Limited | Inhalation device |
US5860419A (en) * | 1990-03-02 | 1999-01-19 | Glaxo Group Limited | Inhalation device |
DE4106379C2 (en) * | 1990-03-02 | 1998-09-24 | Glaxo Group Ltd | Inhaler and medication pack therefor |
GB2246299A (en) * | 1990-06-08 | 1992-01-29 | Glaxo Group Ltd | Medicament-containing article and device therefor. |
US5724959A (en) * | 1990-10-02 | 1998-03-10 | Aea Technology Plc | Powder inhaler with specific orifice and baffle arrangement |
GB2253200A (en) * | 1991-02-01 | 1992-09-02 | Harris Pharma Ltd | Inhalation apparatus and fracturable capsule for use therewith |
US5715810A (en) * | 1991-07-25 | 1998-02-10 | Sepracor Inc. | Inhalation devices |
US5529059A (en) * | 1991-08-01 | 1996-06-25 | Sepracor Inc. | Inhalation devices |
US5337740A (en) * | 1991-08-01 | 1994-08-16 | New England Pharmaceuticals, Inc. | Inhalation devices |
US5645050A (en) * | 1991-12-20 | 1997-07-08 | Boehringer Ingelheim Kg | Powder inhaler with powder carrier consisting of regular microstructures |
GB2264237A (en) * | 1992-02-05 | 1993-08-25 | Robert Edward Newell | An inhaler |
DE19500764A1 (en) * | 1995-01-13 | 1996-07-25 | Asta Medica Ag | Device for administering medication in airstream |
DE19500764C2 (en) * | 1995-01-13 | 2001-09-27 | Sofotec Gmbh & Co Kg | Device for administering medication in solid form, finely distributed in an air stream |
US6672304B1 (en) | 1995-06-08 | 2004-01-06 | Innovative Devices, Llc | Inhalation actuated device for use with metered dose inhalers (MDIs) |
US6729324B2 (en) | 1995-06-08 | 2004-05-04 | Innovative Devices, Llc. | Inhalation actuated device for use with metered dose inhalers (MDIs) |
US5881719A (en) * | 1995-06-30 | 1999-03-16 | Asta Medica Aktiengesellschaft | Inhaler for administering medicaments from blister packs |
US6550477B1 (en) | 1995-08-02 | 2003-04-22 | Innovative Devices, Llc | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US6561186B2 (en) | 1995-08-02 | 2003-05-13 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
EP1618911A2 (en) * | 1999-12-10 | 2006-01-25 | Hitachi, Ltd. | Blister pack for an inhalant medicator |
EP1618910A3 (en) * | 1999-12-10 | 2006-02-08 | Hitachi, Ltd. | Blister pack for an inhalant medicator |
US6810872B1 (en) | 1999-12-10 | 2004-11-02 | Unisia Jecs Corporation | Inhalant medicator |
EP1106196A2 (en) * | 1999-12-10 | 2001-06-13 | Unisia Jecs Corporation | Inhalant medicator |
EP1106196B1 (en) * | 1999-12-10 | 2006-08-02 | Hitachi, Ltd. | Blister pack for an inhalant medicator |
EP1618910A2 (en) * | 1999-12-10 | 2006-01-25 | Hitachi, Ltd. | Blister pack for an inhalant medicator |
EP1618911A3 (en) * | 1999-12-10 | 2006-05-31 | Hitachi, Ltd. | Blister pack for an inhalant medicator |
US7318436B2 (en) | 2000-05-10 | 2008-01-15 | Innovative Devices, Llc | Medicament container with same side airflow inlet and outlet and method of use |
EP2067784A2 (en) | 2000-08-05 | 2009-06-10 | Glaxo Group Limited | 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivates as anti-flammatory agents |
EP2348032A2 (en) | 2000-08-05 | 2011-07-27 | Glaxo Group Limited | 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
EP1775305A2 (en) | 2000-08-05 | 2007-04-18 | Glaxo Group Limited | 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
WO2002012266A1 (en) | 2000-08-05 | 2002-02-14 | Glaxo Group Limited | 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
US7442719B2 (en) | 2001-02-14 | 2008-10-28 | Glaxo Group Limited | Methods using phenethanolamine derivatives for treatment of respiratory diseases |
US7135600B2 (en) | 2001-02-14 | 2006-11-14 | Glaxo Group Limited | Phenethanolamine derivatives for treatment of respiratory diseases |
US7045658B2 (en) | 2001-03-22 | 2006-05-16 | Glaxo Group Limited | Formailide derivatives as beta2-adrenoreceptor agonists |
EP2039700A2 (en) | 2001-04-30 | 2009-03-25 | Glaxo Group Limited | Novel anti-inflammatory androstane derivatives |
US8198483B2 (en) | 2001-09-14 | 2012-06-12 | Glaxo Group Limited | Phenethanolamine derivatives for treatment of respiratory diseases |
US7776895B2 (en) | 2001-09-14 | 2010-08-17 | Glaxo Group Limited | Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases |
US7361787B2 (en) | 2001-09-14 | 2008-04-22 | Glaxo Group Limited | Phenethanolamine derivatives for treatment of respiratory diseases |
EP2042168A1 (en) | 2001-09-14 | 2009-04-01 | Glaxo Group Limited | Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
USRE44874E1 (en) | 2001-09-14 | 2014-04-29 | Glaxo Group Limited | Phenethanolamine derivatives for treatment of respiratory diseases |
US7982067B2 (en) | 2001-09-14 | 2011-07-19 | Glaxo Group Limited | Phenethanolamine derivatives for treatment of respiratory diseases |
US7439393B2 (en) | 2001-09-14 | 2008-10-21 | Glaxo Group Limited | Phenethanolamine derivatives for treatment of respiratory diseases |
US8337816B2 (en) | 2001-09-17 | 2012-12-25 | Glaxo Group Limited | Dry powder medicament formulations |
EP2363121A1 (en) | 2002-02-04 | 2011-09-07 | Glaxo Group Limited | Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions |
EP1487524A4 (en) * | 2002-03-15 | 2011-01-12 | Valois Sas | Dry powder inhaler |
EP1487524A1 (en) * | 2002-03-15 | 2004-12-22 | Valois, SAS | Dry powder inhaler |
US7271197B2 (en) | 2002-04-25 | 2007-09-18 | Glaxo Group Limited | Phenethanolamine derivatives |
US7402598B2 (en) | 2002-07-25 | 2008-07-22 | Glaxo Group Limited | Arylethanolamine β2-adrenoreceptor agonist compounds |
US7442839B2 (en) | 2002-10-28 | 2008-10-28 | Glaxo Group Limited | Phenethanolamine derivative for the treatment of respiratory diseases |
US7538127B2 (en) | 2003-02-14 | 2009-05-26 | Glaxo Group Limited | Medicinal compounds |
US7495010B2 (en) | 2003-07-17 | 2009-02-24 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US7576096B2 (en) | 2003-10-14 | 2009-08-18 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US7579361B2 (en) | 2003-10-14 | 2009-08-25 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US7507747B2 (en) | 2003-10-17 | 2009-03-24 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US7563803B2 (en) | 2003-11-04 | 2009-07-21 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
WO2005046586A2 (en) | 2003-11-04 | 2005-05-26 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
US7906531B2 (en) | 2003-11-04 | 2011-03-15 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
US7439255B2 (en) | 2003-11-04 | 2008-10-21 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US7294650B2 (en) | 2003-12-17 | 2007-11-13 | Glaxo Group Limited | Benzothiophen and thiochrone containing phenethanolamine derivatives for the treatment of respiratory disorders |
US7384946B2 (en) | 2004-03-17 | 2008-06-10 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
US7846973B2 (en) | 2004-04-02 | 2010-12-07 | Theravance, Inc. | Chemical process and new crystalline form |
WO2005104745A2 (en) | 2004-04-27 | 2005-11-10 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US7498440B2 (en) | 2004-04-27 | 2009-03-03 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US7488827B2 (en) | 2004-04-27 | 2009-02-10 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US9144571B2 (en) | 2004-04-27 | 2015-09-29 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US9045469B2 (en) | 2004-04-27 | 2015-06-02 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US8853404B2 (en) | 2004-04-27 | 2014-10-07 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
EP2570128A1 (en) | 2004-04-27 | 2013-03-20 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US8183257B2 (en) | 2004-04-27 | 2012-05-22 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US8575347B2 (en) | 2004-04-27 | 2013-11-05 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US8309572B2 (en) | 2004-04-27 | 2012-11-13 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US7598267B2 (en) | 2004-05-13 | 2009-10-06 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
EP3199164A1 (en) | 2005-02-10 | 2017-08-02 | Glaxo Group Limited | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
US9365905B2 (en) | 2005-02-10 | 2016-06-14 | Dmv-Fonterra Excipients Technology Gmbh | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
EP2447266A1 (en) | 2005-03-25 | 2012-05-02 | Glaxo Group Limited | Pyrimidopyridine compound used as a CSBP/RK/p38 modulator |
WO2006104889A2 (en) | 2005-03-25 | 2006-10-05 | Glaxo Group Limited | Novel compounds |
EP2436686A1 (en) | 2005-03-25 | 2012-04-04 | Glaxo Group Limited | Pyrimidopyridine compound used as a CSBP/RK/p38 modulator |
US7767691B2 (en) | 2005-08-18 | 2010-08-03 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists containing an azoniabiocyclo[2.2.1] heptane ring system |
US8434476B2 (en) | 2006-09-26 | 2013-05-07 | Alfred Von Schuckmann | Dispenser for pulverulent substances |
WO2008118724A1 (en) | 2007-03-23 | 2008-10-02 | Smithkline Beecham Corporation | Indole carboxamides as ikk2 inhibitors |
US7956065B2 (en) | 2008-09-08 | 2011-06-07 | Biovail Laboratories International (Barbados) S.R.L. | Pharmaceutical compounds |
US11116721B2 (en) | 2009-02-26 | 2021-09-14 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
WO2010147947A2 (en) | 2009-06-16 | 2010-12-23 | Schering Corporation | NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF |
US11090294B2 (en) | 2009-12-01 | 2021-08-17 | Glaxo Group Limited | Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist |
WO2012028662A1 (en) | 2010-08-31 | 2012-03-08 | Glaxo Group Limited | Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same |
EP2954888A1 (en) | 2010-08-31 | 2015-12-16 | GlaxoSmithKline Intellectual Property Development Limited | Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same |
WO2012028663A1 (en) | 2010-08-31 | 2012-03-08 | Glaxo Group Limited | Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same |
US9297813B2 (en) | 2010-11-11 | 2016-03-29 | Agency For Science, Technology And Research | Targeting metabolic enzymes in human cancer |
WO2013045431A1 (en) | 2011-09-27 | 2013-04-04 | Glaxo Group Limited | Sulfonamide compounds and their use in the modulation retinoid - related orphan receptor |
WO2013160419A1 (en) | 2012-04-27 | 2013-10-31 | Glaxo Group Limited | Novel compounds |
WO2013160418A1 (en) | 2012-04-27 | 2013-10-31 | Glaxo Group Limited | Novel compounds |
WO2014085474A1 (en) | 2012-11-28 | 2014-06-05 | Intercept Pharmaceuticals, Inc. | Treatment of pulmonary disease |
WO2016142426A1 (en) | 2015-03-11 | 2016-09-15 | Glaxosmithkline Intellectual Property Development Limited | Tslp binding proteins |
EP3766878A1 (en) | 2015-06-15 | 2021-01-20 | GlaxoSmithKline Intellectual Property Development Limited | Nrf2 regulators |
WO2016203401A1 (en) | 2015-06-15 | 2016-12-22 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 regulators |
WO2016203400A1 (en) | 2015-06-15 | 2016-12-22 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 regulators |
EP3782996A1 (en) | 2015-06-15 | 2021-02-24 | GlaxoSmithKline Intellectual Property Development Limited | Nrf2 regulators |
WO2017029602A2 (en) | 2015-08-16 | 2017-02-23 | Glaxosmithkline Intellectual Property Development Limited | Compounds for use in antibacterial applications |
WO2017060855A1 (en) | 2015-10-06 | 2017-04-13 | Glaxosmithkline Intellectual Property Development Limited | Arylcyclohexyl pyrazoles as nrf2 regulators |
WO2017060854A1 (en) | 2015-10-06 | 2017-04-13 | Glaxosmithkline Intellectual Property Development Limited | Biaryl pyrazoles as nrf2 regulators |
WO2018055527A1 (en) | 2016-09-20 | 2018-03-29 | Glaxosmithkline Intellectual Property (No.2) Limited | Trpv4 antagonists |
WO2018055526A1 (en) | 2016-09-20 | 2018-03-29 | Glaxosmithkline Intellectual Property (No.2) Limited | Trpv4 antagonists |
WO2018055524A1 (en) | 2016-09-20 | 2018-03-29 | Glaxosmithkline Intellectual Property (No.2) Limited | Trpv4 antagonists |
WO2018104766A1 (en) | 2016-12-06 | 2018-06-14 | Glaxosmithkline Intellectual Property Development Limited | 3-(2,3-dihydro-1h-inden-5-yl)propanoic acid derivatives and their use as nrf2 regulators |
WO2018109641A1 (en) | 2016-12-12 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | 3-carboxylic acid pyrroles as nrf2 regulators |
WO2018109642A1 (en) | 2016-12-12 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | N-aryl pyrazoles as nrf2 regulators |
WO2018109647A1 (en) | 2016-12-14 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Bisaryl amides as nrf2 regulators |
WO2018109643A1 (en) | 2016-12-14 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Bisaryl heterocycles as nrf2 acti |
WO2018109648A1 (en) | 2016-12-14 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | 3-oxo-1,4-diazepinyle compounds as nrf2 activators |
WO2018109646A1 (en) | 2016-12-15 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 compounds |
WO2018109649A1 (en) | 2016-12-15 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Ether linked triazoles as nrf2 regulators |
WO2018200425A1 (en) | 2017-04-24 | 2018-11-01 | Cocrystal Pharma, Inc. | Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication |
US11014941B2 (en) | 2017-04-24 | 2021-05-25 | Cocrystal Pharma, Inc. | Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication |
WO2019116230A1 (en) | 2017-12-11 | 2019-06-20 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome |
WO2019116231A1 (en) | 2017-12-11 | 2019-06-20 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome |
WO2019115640A1 (en) | 2017-12-15 | 2019-06-20 | Glaxosmithkline Intellectual Property Development Limited | 6-(morpholin-4-yl)-pyridin-2-yl-1h-pyrrolo[3,2-b]pyridine derivatives as m-tor inhibitors |
WO2019141694A1 (en) | 2018-01-17 | 2019-07-25 | Glaxosmithkline Intellectual Property Development Limited | Pi4kiiibeta inhibitors |
WO2019224667A1 (en) | 2018-05-23 | 2019-11-28 | Glaxosmithkline Intellectual Property Development Limited | Indanes as nrf2 activators |
WO2020023813A1 (en) | 2018-07-27 | 2020-01-30 | Cocrystal Pharma, Inc. | Pyrrolo[2,3-b]pyridin derivatives as inhibitors of influenza virus replication |
WO2020055858A1 (en) | 2018-09-10 | 2020-03-19 | Cocrystal Pharma, Inc. | Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication |
WO2020081751A1 (en) | 2018-10-17 | 2020-04-23 | Cocrystal Pharma, Inc. | Combinations of inhibitors of influenza virus replication |
WO2020102270A1 (en) | 2018-11-13 | 2020-05-22 | Cocrystal Pharma, Inc. | Formulations of influenza therapeutics |
WO2020112716A1 (en) | 2018-11-26 | 2020-06-04 | Cocrystal Pharma, Inc. | Inhibitors of influenza virus replication |
WO2020249652A1 (en) | 2019-06-13 | 2020-12-17 | Glaxosmithkline Intellectual Property Development Limited | Pyridyl or pyrimidyl mtor kinase inhibitors |
WO2021188620A1 (en) | 2020-03-17 | 2021-09-23 | Cocrystal Pharma Inc. | Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication |
WO2021206876A1 (en) | 2020-04-10 | 2021-10-14 | Cocrystal Pharma, Inc. | Inhibitors of norovirus and coronavirus replication |
WO2021216547A1 (en) | 2020-04-20 | 2021-10-28 | Sorrento Therapeutics, Inc. | Pulmonary administration of ace2 polypeptides |
WO2022175425A1 (en) | 2021-02-22 | 2022-08-25 | Glaxosmithkline Intellectual Property Development Limited | Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection |
WO2022179967A1 (en) | 2021-02-23 | 2022-09-01 | Glaxosmithkline Intellectual Property (No.2) Limited | Vadadustat for treating covid-19 in a hospitalized subject |
WO2023014758A1 (en) | 2021-08-03 | 2023-02-09 | Cocrystal Pharma, Inc. | Inhibitors for coronaviruses |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2129691A (en) | Devices for administering medicaments to patients | |
GB2169265A (en) | Pack for medicament | |
US4778054A (en) | Pack for administering medicaments to patients | |
CA1272917A (en) | Devices for administering medicaments to patients | |
EP2432536B1 (en) | Rotary cassette system for dry powder inhaler | |
JP4044620B2 (en) | System for administration by inhalation of powdered drugs | |
CA1055350A (en) | Insufflator | |
GB2340758A (en) | Drug dispensing system | |
IE55508B1 (en) | Medical administration devices | |
HU216405B (en) | Dry powder inhalator medicament carrier | |
JPS5988158A (en) | Apparatus for dosing drug to patient and pack used therefor | |
DK173079B1 (en) | Hand-held inhaler for powder or liq. medical inhalants - which are in dose sized blisters of circular disc blister pack | |
FI81255C (en) | Packaging for use in inhalation device | |
CA1236736A (en) | Device for administering medicament to patients | |
IE56060B1 (en) | Medicament-containing pack | |
NL193681C (en) | Packaging for medicines. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE20 | Patent expired after termination of 20 years |
Effective date: 20031006 |